These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 17038459)

  • 1. Agreement of Mexican rheumatologists with the ASsessment in Ankylosing Spondylitis International Working Group and the EUropean League Against Rheumatism recommendations for the management of ankylosing spondylitis.
    Simón JA; Burgos-Vargas R
    Ann Rheum Dis; 2006 Nov; 65(11):1535-6. PubMed ID: 17038459
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment guidelines for ankylosing spondylitis and its effect on Mexican rheumatology].
    Burgos-Vargas R; Abud-Mendoza C; Díaz-Jouanen E; Garza-Elizondo MA; Medrano-Ramírez G; Orozco-Alcalá J; Pacheco-Tena C; Pineda-Villaseñor C; Carlos-Pozos J; Ramos-Niembro F; Robles-San Román M; Santana-Sahagún E
    Gac Med Mex; 2009; 145(1):41-9. PubMed ID: 19256410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ASAS/EULAR recommendations for the management of ankylosing spondylitis: the patient version.
    Kiltz U; van der Heijde D; Mielants H; Feldtkeller E; Braun J;
    Ann Rheum Dis; 2009 Sep; 68(9):1381-6. PubMed ID: 18930993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ankylosing spondylitis antirheumatic drug trials. I. Effects of standardization procedures on observer dependent outcome measures.
    Bellamy N; Buchanan WW; Esdaile JM; Fam AG; Kean WF; Thompson JM; Wells GA; Campbell J
    J Rheumatol; 1991 Nov; 18(11):1701-8. PubMed ID: 1787492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence-based recommendations for the management of ankylosing spondylitis: systematic literature search of the 3E Initiative in Rheumatology involving a broad panel of experts and practising rheumatologists.
    Sidiropoulos PI; Hatemi G; Song IH; Avouac J; Collantes E; Hamuryudan V; Herold M; Kvien TK; Mielants H; Mendoza JM; Olivieri I; Østergaard M; Schachna L; Sieper J; Boumpas DT; Dougados M
    Rheumatology (Oxford); 2008 Mar; 47(3):355-61. PubMed ID: 18276738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Danish recommendations on treatment of ankylosing spondylitis and spondyloarthritis based on multinational project initiative].
    Pedersen SJ; Madsen OR; Erlendsson J; Schiøttz-Christensen B; Sørensen IJ; Andersen LS; Ostergaard M
    Ugeskr Laeger; 2008 Dec; 170(49):4044-50. PubMed ID: 19087747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient and rheumatologist perspectives on glucocorticoids: an exercise to improve the implementation of the European League Against Rheumatism (EULAR) recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases.
    van der Goes MC; Jacobs JW; Boers M; Andrews T; Blom-Bakkers MA; Buttgereit F; Caeyers N; Choy EH; Cutolo M; Da Silva JA; Guillevin L; Holland M; Kirwan JR; Rovensky J; Saag KG; Severijns G; Webber S; Westhovens R; Bijlsma JW
    Ann Rheum Dis; 2010 Jun; 69(6):1015-21. PubMed ID: 19762359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescription rheumatology practices among Mexican specialists.
    Goycochea-Robles MV; Arce-Salinas CA; Guzmán-Vázquez S; Cardiel-Ríos MH
    Arch Med Res; 2007 Apr; 38(3):354-9. PubMed ID: 17350489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Which patients with ankylosing spondylitis should be treated with tumour necrosis factor inhibiting therapy? A survey among Dutch rheumatologists.
    Landewé R; Rump B; van der Heijde D; van der Linden S
    Ann Rheum Dis; 2004 May; 63(5):530-4. PubMed ID: 15082483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT).
    van der Heijde D; Dijkmans B; Geusens P; Sieper J; DeWoody K; Williamson P; Braun J;
    Arthritis Rheum; 2005 Feb; 52(2):582-91. PubMed ID: 15692973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update of the literature review on treatment with biologics as a basis for the first update of the ASAS/EULAR management recommendations of ankylosing spondylitis.
    Baraliakos X; van den Berg R; Braun J; van der Heijde D
    Rheumatology (Oxford); 2012 Aug; 51(8):1378-87. PubMed ID: 22427410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ankylosing spondylitis antirheumatic drug trials. II. Tables for calculating sample size for clinical trials.
    Bellamy N; Buchanan WW; Esdaile JM; Fam AG; Kean WF; Thompson JM; Wells GA; Campbell J
    J Rheumatol; 1991 Nov; 18(11):1709-15. PubMed ID: 1787493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ASsessment in Ankylosing Spondylitis International Working Group/Spondylitis Association of America recommendations for conducting clinical trials in ankylosing spondylitis.
    van der Heijde D; Dougados M; Davis J; Weisman MH; Maksymowych W; Braun J; Hallegua DS; Bruckel J;
    Arthritis Rheum; 2005 Feb; 52(2):386-94. PubMed ID: 15693009
    [No Abstract]   [Full Text] [Related]  

  • 14. Health-related quality of life outcomes in patients with active ankylosing spondylitis treated with adalimumab: results from a randomized controlled study.
    Davis JC; Revicki D; van der Heijde DM; Rentz AM; Wong RL; Kupper H; Luo MP
    Arthritis Rheum; 2007 Aug; 57(6):1050-7. PubMed ID: 17665483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence-based recommendations for the management of ankylosing spondylitis: results of the Hellenic working group of the 3E Initiative in Rheumatology.
    Raptopoulou A; Sidiropoulos P; Siakka P; Boki K; Drosos AA; Aslanidis S; Karras D; Pikazis D; Vassilopoulos D; Karassa F; Boumpas DT;
    Clin Exp Rheumatol; 2008; 26(5):784-92. PubMed ID: 19032809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapy (excluding biotherapies) for ankylosing spondylitis: development of recommendations for clinical practice based on published evidence and expert opinion.
    Lavie F; Pavy S; Dernis E; Goupille P; Cantagrel A; Tebib J; Claudepierre P; Flipo RM; Le Loët X; Maillefert JF; Mariette X; Saraux A; Schaeverbeke T; Wendling D; Combe B
    Joint Bone Spine; 2007 Jul; 74(4):346-52. PubMed ID: 17590370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Patient evaluation of the German version of the ASAS/EULAR recommendations for the management of ankylosing spondylitis].
    Kiltz U; Feldtkeller E; Braun J
    Z Rheumatol; 2008 Dec; 67(8):694-700, 702. PubMed ID: 19011877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation exercise of the Ankylosing Spondylitis Assessment Study (ASAS) group response criteria in ankylosing spondylitis patients treated with biologics.
    Stone MA; Inman RD; Wright JG; Maetzel A
    Arthritis Rheum; 2004 Jun; 51(3):316-20. PubMed ID: 15188313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ankylosing spondylitis antirheumatic drug trials. III. Setting the delta for clinical trials of antirheumatic drugs--results of a consensus development (Delphi) exercise.
    Bellamy N; Buchanan WW; Esdaile JM; Fam AG; Kean WF; Thompson JM; Wells GA; Campbell J
    J Rheumatol; 1991 Nov; 18(11):1716-22. PubMed ID: 1787494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A major subset of patients with ankylosing spondylitis followed up in tertiary clinical care require anti-tumour necrosis factor alpha biological treatments according to the current guidelines.
    Temel M; Atagündüz P; Direskeneli H
    Ann Rheum Dis; 2005 Sep; 64(9):1383-4. PubMed ID: 16100352
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.